Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting . Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026013, 2026. DOI: 10.4084/MJHID.2026.013. Disponível em: https://www.mjhid.org/mjhid/article/view/6195. Acesso em: 30 apr. 2026.